33
Prescribing For Young People With Learning Disability Dr Don MacFarlane PhD., MB., MRCPsych, MSc., DPM Lakeview, Gransha Park, Derry

Prescribing For Young People With Learning Disability

  • Upload
    mindy

  • View
    44

  • Download
    0

Embed Size (px)

DESCRIPTION

Prescribing For Young People With Learning Disability. Dr Don MacFarlane PhD., MB., MRCPsych , MSc., DPM Lakeview, Gransha Park, Derry. Ethical Issues, Holistic Assessment and Clinical Practice. Food For Thought. - PowerPoint PPT Presentation

Citation preview

Page 1: Prescribing For Young People     With Learning Disability

Prescribing For Young People With Learning DisabilityDr Don MacFarlane PhD., MB., MRCPsych, MSc., DPM

Lakeview, Gransha Park, Derry

Page 2: Prescribing For Young People     With Learning Disability

Ethical Issues, Holistic Assessment and Clinical Practice

Page 3: Prescribing For Young People     With Learning Disability

Food For Thought

‘We forfeit three-quarters of ourselves to be like other people’ Arthur Schopenaur

‘If a man does not keep pace with his companions, perhaps it is because he hears a different drummer. Let him step to the music that he hears, however measured or far away’ Henry David Thoreau

Page 4: Prescribing For Young People     With Learning Disability

Developmental Disorder• Onset during gestation, from birth or from early childhood• Deviation from the average in how the child perceives, thinks

and feels• Encompasses domains of behaviour• Accompanied by distress and problems in performance

Page 5: Prescribing For Young People     With Learning Disability

Ethical Issues in MLD and SLD• Seeking Consent

capability of taking decisionacting voluntarily without undue persuasiongiven enough information

• Good Practicepatient’s welfare is first concernsafety, dignity and comfort is maintainedtreat with dignity and respectlisten to concerns and preferencesbe open and honest

Page 6: Prescribing For Young People     With Learning Disability

FRASER GUIDELINES• Child capable of giving consent• Maturity and understanding• Nature of consent required• Can make reasonable assessment of the facts• Knows advantages and disadvantages• Consent can be considered true

Page 7: Prescribing For Young People     With Learning Disability

MEDICAL NEGLECT• Child is at risk of harm if inaction• Recommended care offers significant benefit• Expected benefit is significantly greater than risk• Access to care is available and not being used• Caregiver understands the medical advice being given

Page 8: Prescribing For Young People     With Learning Disability

MENTAL HEALTH ORDER SCENARIOS• SCENARIO #1 MLD + Schizophrenia + Lymphoma + Injunction• SCENARIO #2 MLD + Delusional + Forensic + Tribunal• SCENARIO #3 HFA + Bed Closures + Medical School + Infringrements

Page 9: Prescribing For Young People     With Learning Disability

Dysmorphology in MLD and SLD• Cortical invaginations or cerebromalacia• Agenesis or microcephaly• Lateral ventricle malformations• Anomalies of corpus callosum• Subgenual cingulate gyrus• Increased CSF• Cerebellar and vermal hypogenesis• Basal ganglia reduction

Page 10: Prescribing For Young People     With Learning Disability

PHYSICAL EXAMINATION IN SLD• Head circumference• Height and weight• Canthal distance• Flat philtrum• Intraorbital distance• Breadth of forehead• Facial muscle movement• Clinodactly• Abnormal nails

Page 11: Prescribing For Young People     With Learning Disability

SPECIALIST PRESCRIBING• Person-centred approach• Evidence-based• Care pathways (collaborative with mainstream)• Maximise independence and social inclusion• Minimise hospitalisation• Promote safeguarding• Fulfil legal and ethical requirements

Page 12: Prescribing For Young People     With Learning Disability

LD Care Pathways• Psychological

mental comorbidity and behaviour problems offendingdevelopmental pervasive disorders.

• Physical sensoryprofound, multiple or complex nutrition, epilepsy

Page 13: Prescribing For Young People     With Learning Disability

BEXLEY Audit Findings• 57% of clients regularly reviewed• 29% had Challenging Behaviour Risk Assessment (FACE?)• 51% had written care plan• 22% had keyworker• 32% had reasons recorded for no further assessment • 55% had blood profiles regularly recorded• 24% had diagnosis of autism; 68% had mental illness

Page 14: Prescribing For Young People     With Learning Disability

Emotional Instability• Conflicts with others• Inability to cope with being thwarted• Inability to consider consequences• ‘Meltdowns’• Confusion about differentness• Inability to visualise aims and preferences• Self-injurious behaviour

Page 15: Prescribing For Young People     With Learning Disability

SWAP 200• At the mercy of spiralling emotions• No stable image of self• Anxiety about rejection and abandonment• Need for external soothing• Elicits mirrored feelings in others• Has disregard for safety or welfare of self and others• Unawareness of others’ needs

Page 16: Prescribing For Young People     With Learning Disability

Clinical Depression• Ego Threat – sadness, failure, loss of pleasure, blame,

punishment, worthless• Vegetation – sleep, fatigue, appetite, libido• Arousal – energy, agitation, irritability, concentration, focus

Page 17: Prescribing For Young People     With Learning Disability

Developmental Tasks• Capable v.Helpless• Adventurous v. Avoidant• Persistent v. Quitting• Affectionate v. Detached• Assertive v. Submissive• Volatile v. Calm

Page 18: Prescribing For Young People     With Learning Disability

Behavioural Modelling• Self Fulfilment (Maslow)• Aspirations• Norms• Scripts• Empathy• Congruence• Goals

Page 19: Prescribing For Young People     With Learning Disability

Behavioural Models• Reasoned Action (Ajzen)• Congruence (Frijda)• Dynamic Attachment (Crittenden)• Behavioural Analysis (Snyder)• Procedural Sequencing (Chaiken)• Reciprocity (Gambrill)• Mentalising (Fonagy)

Page 20: Prescribing For Young People     With Learning Disability

Primary Emotions• Anger – demeaning offence against self• Anxiety – uncertain threat against self• Sadness – experience of irrevocable loss • Happiness – progress towards a goal• Pride – achievement of a goal• Love – affection for idealised other

Page 21: Prescribing For Young People     With Learning Disability

Secondary Emotions• Relief• Frustration• Hostility• Disgust• Hurt• Embarassment

Page 22: Prescribing For Young People     With Learning Disability

ACTING OUT #1ADHD Bipolar Attached Trauma PD ASD

Duration Constant Cyclical Reactive Reactive Constant ConstantAttention Short Distracted Stressed Avoidant Selective SensoryImpulsivity

Careless Hedonistic Futile Triggered Reactive Thwarted

Esteem Tasked Grandiose Unloved Worthless Depleted FragmentsMood Normal Elated Needy Sad Empty BrittleControl Disrupts Hassles Sneaks Lacks Exhausts Exhausts

Page 23: Prescribing For Young People     With Learning Disability

ACTING OUT #2ADHD Bipolar Attache

dTrauma Personali

tyASD

Opposition

Disrupts Defies Sneaks Projects Switches Resists

Blame Deflects Denies Projects Accepts Confirms CentredLying Deflects Uses Conjures Conceals Believes WeakTemper Excited Frustrated Bottled Hidden Explodes ReactiveEntitled Fleeting Grandiose False Oppressed Coercive ReactiveSensitivity

Blinkered Hot Misreads Frightened Smoulder Hot

Page 24: Prescribing For Young People     With Learning Disability

ACTING #3ADHD Bipolar Attached Trauma Personali

tyASD

Awareness

Flooded Egoistic Self Split Self Myopic

Peers Transient Arguing Needy Detached Isolated DetachedMeds 1 MPD Risperdal Lustral Lustral RisperdalMeds2 Strattera Zyprexa Prozac Prozac ComorbidMeds 3 Clonidine Seroquel Circadin ComorbidMeds 4 Buspirone Abilify Clonidine Comorbid

Page 25: Prescribing For Young People     With Learning Disability

CAVEATS WITH SSRIs• SSRIs can cause A-V defects in first trimester of pregnancy• Impotence from SSRIs can be counteracted by Periactin• Contraceptives can be impaired by modafinil• Risperidone can induce hypomania• Fluoxetine can double blood levels of mood-stabilisers• Tryptophan can cause serotonin overload• ‘Poop-out’ on fluoxetine occurs in 20% of cases

Page 26: Prescribing For Young People     With Learning Disability

CAVEATS with NEUROLEPTICS• Haloperidol loses its anxiolytic effect in higher doses• Abilify can improve executive functioning• Abilify can cause suicidality due to akathisia• High blood sugars with olanzapine if relative has diabetes• Risperidone does not work above 6mg daily in adults• High prolactin levels stunt growth and delay puberty

Page 27: Prescribing For Young People     With Learning Disability

CAVEATS with ANTICONVULSANTS• Suicide risk can be increased with anticonvulsants• Fortnightly checks of LFTS and serum levels of Tegretol• Children and adolescents are resistant to mood-stabilising• Children with ADHD are prone to have behavioural side-

effects from mood-stabilisers• Atypical antipsychotics are just as effective

Page 28: Prescribing For Young People     With Learning Disability

CAVEATS with ADHD medication• ADHD Assessment Instruments are not geared to MLD• Rebound and ‘Poop Out’ are not reasons for discontinuation• ADHD is easily mistaken for other conditions such as bipolar• Developmental charts should be regularly consulted• Bone profile and scanning should be considered• Atomoxetine and SSRI combo is to be avoided• Cardiac history and QTc should be monitored

Page 29: Prescribing For Young People     With Learning Disability

CASE STUDY (MLD+ASD+ADHD+BPD)• Aged 5 – ASD (aggression, agarophobic, insomnia, hyper) > risperidone 1mg nocte> global improvement ‘a new man’• Aged 6 – regressed > olanzapine 2.5mg nocte > mum says needs dose increased > 5mg nocte > excellent improvement• Aged 9 – regressed > risperidone 2.75mg• Aged 9 – ‘high and anxious’ > risperidone 1mg > labile, insomnia • Aged 13 - > ADHD > risperidone 1.5 mg > ‘excellent progress’

Page 30: Prescribing For Young People     With Learning Disability

CASE STUDY continued

• Aged 13 – BST > mood improved, less agitated, on risperidone 1.5mg + >melatonin > ‘brilliant’ > ADHD?

• Aged 13 – YMRS, violent to Mum, BST continues >EEG > ADHD ‘confirmed’ > Medikinet > ‘good benefit’, ‘content’ relaxed’

• Aged 14 – Medikinet stopped due rebound effect > ‘back to normal’• Aged 14 – ‘giddy and lively’ > atomoxetine > EMW but ‘good effect’,

‘moods improved’, ‘happier and less tearful’• Aged 15 – giddy, echolalia, repetitive movement > BPD > valproate +

risperidone + atomoxetine• Aged 15 – atomoxetine discontinued > clonidine 0.75 mg

Page 31: Prescribing For Young People     With Learning Disability

Useful Websites• http://amberlist.wordpress.com

‘Prescribing for Young People’• http://johnalstonmd.com/docs/ADD_Bipolar_RAD.pdf

‘Juvenile Bipolar Disorder’ (John Alston, Baltimore)• http://www.familyrelationsinstitute.org/include/dmm_model.htm

‘Dynamic Maturational Model’ (Patricia Crittenden, Miami)

Page 32: Prescribing For Young People     With Learning Disability

Useful Websites #2• http://www.merseycare.nhs.uk/Library/What_we_do/Clinical_Services/Pharmacy/Le

arningDisabilities-Finalv3.pdf ‘Merseyside Clinical Guidelines’

• http://www.rcpsych.ac.uk/pdf/FutureroleofpsychiatristsinLD%20services.pdf ‘Future Role of Psychiatrist in Learning Disability’ RCPsych

• http://depts.washington.edu/dbpeds/Dysmorphology%20Training%20Manual%201-10-08%20(2).pdf‘Dysmorphology Training Manual’.

• http://www.dhsspsni.gov.uk/consent-guidepart4.pdfSeeking Consent in MLD, DHSSPNI Document

• http://pediatrics.aappublications.org/content/120/6/1385.fullRecognising Medical Neglect

Page 33: Prescribing For Young People     With Learning Disability

Thank You For Listening